Vitamin B12, is an important water-soluble vitamin. It mainly helps in nerve tissue health, brain function and red blood cells production. Also, vitamin helps in bone formation, mineralization, and growth. In large surveys in the United States and the United Kingdom, approx. 6% of those aged more than 60 years are Vitamin B12 deficient.

The rate is much high in underdeveloped and developing countries such as Africa, Vienna and some parts of South-East Asia. Vitamin B12 deficiency treatment results majorly due to decreased dietary intake and impaired absorption.

Vitamin B12 deficiency causes balance problems, memory loss, difficulty in thinking, reasoning, anemia etc. The main dietary sources can be meat, egg, salmon, and other dairy products. Apart from that, injectable vitamin B12 formulations are also available in the market like hydroxocobalamin and cyanocobalamin. But treatment with vitamin pills is mostly used as it can be easily incorporated in the regime.

Request for a sample here @ https://www.persistencemarketresearch.com/samples/31730

Increasing prevalence of malnutrition among children across the globe is expected to drive the growth of vitamin B12 deficiency treatment market. An estimated 6% of people in the US and UK suffer from vitamin B12 deficiency so there is a vast scope for vitamin B12 deficiency treatment market to grow.

Anemia is one of the major problem in underdeveloped countries which majorly occur due to Vitamin B12 deficiency also, it can help to cure atropic gastritis which occur due to Vitamin B12 deficiency which in turn drive the growth of Vitamin B12 deficiency treatment market. Studies have shown that various food industries can also act as a major puller for vitamin B12 deficiency treatment market.

Many doctors in US and UK are recommending the use of Vitamin B12 oral drugs which also can lead the growth of vitamin B12 deficiency treatment market. Early detection of this deficiency using advanced techniques like ELISA can help the vitamin B12 deficiency treatment market to grow more. The underdeveloped countries lack knowledge and availability for the treatment which can restrict the growth of vitamin B12 deficiency treatment market.

Ask for Table Of Content here @ https://www.persistencemarketresearch.com/toc/31730

Market Segmentation

Based on drug type
  • Hydroxocobalamin
  • Cyanocobalamin
 Based on dosage form
  • Powder for reconstitution
  • Solution/ Injection
  • Tablets
  • Nasal sprays
  • Syrups
 Based on Route
  • Intravenous
  • Subcutaneous
  • Oral
  • Nasal
Based on distribution channel
  • Hospital Pharmacy
  • Online sales
  • Retail Pharmacy
  • Drug Stores

Key Players

Some of the profiled key players of vitamin B12 deficiency treatment market that prevalent globally include, Watson Company, Merck and Co. Ltd., Daiichi Sankyo Company, Limited., Dr. Reddy’s Laboratories Ltd., Mylan N.V, Pfizer Inc., Teligent Canada. Other players of vitamin B12 deficiency treatment market include Himalaya Herbal Healthcare, Dabur International Limited.

Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/31730

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com